Blue Jet Healthcare Awarded EcoVadis Silver Medal for Sustainability Excellence
Mumbai: Blue Jet Healthcare Limited has been awarded the prestigious Silver Medal by EcoVadis in recognition of its outstanding sustainability management practices. This achievement places the company among the top 15% globally, reflecting a high standard of performance evaluated across key corporate areas.The EcoVadis assessment covers four critical domains: Environment, Labor and Human Rights, Ethics, and Sustainable Procurement. Blue Jet Health achieved an EcoVadis Sustainability Score of 77 out of 100 by securing the Silver Medal.
Commenting on the significant recognition, Mr. Shiven Akshay Arora, Managing Director, stated that the EcoVadis Silver Medal marks a major milestone in the company’s sustainability journey. He noted that this award reflects the progress made since earning the EcoVadis Committed Badge, underscoring the efforts to strengthen environmental, social, ethical, and governance practices across its operations.
Mr. Arora further attributed the recognition to the collective efforts of employees, business partners, and stakeholders who are committed to embedding environmental, social, and governance (ESG) principles into every aspect of the company's work.
Company Profile
Blue Jet Healthcare, established in 1968, is a specialized manufacturer. The company produces specialty chemicals and pharmaceutical intermediates for global pharmaceutical companies. Blue Jet operates with a core focus on quality assurance, compliance, and governance-led growth.BLUEJET Stock Price Movement
Today, Blue Jet Healthcare Limited shares edged higher to close at ₹589.5 after gaining 0.69%, driven by positive market sentiment toward the pharmaceutical sector. The stock traded with a volume of 447,920 shares and remained within its daily trading range, swinging between a low of ₹575 and a high of ₹600.5.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.